BHI Board

The BHI Board is led by Board Chair, Professor Carol Pollock AO.


photo of Professor Carol Pollock AO

Professor Carol Pollock AO

Professor Carol Pollock AO has an international reputation and has published more than 280 papers in clinical medicine and basic science. She is a renal medicine specialist with extensive experience as a clinician, researcher, lecturer, mentor and advocate.

Professor Pollock is an inaugural Fellow of the Australian Academy of Health and Medical Sciences (2015), was conferred a Vice Chancellors Award for Excellence in Research Supervision (2012), recognised as a ‘Distinguished Professor’ by the University of Sydney (2012) and received the Ministerial Award for Excellence in Cardiovascular Research (2014).

Her health leadership roles have included inaugural Chair of the NSW Agency for Clinical Innovation, Chair of the Clinical Excellence Commission, inaugural Chair of the Northern Sydney Local Health District Board and Director of Kidney Health Australia since 2014.

Professor Pollock chairs the NSW Cardiovascular Research Network and chairs the International Society of Nephrology Meetings Committee, responsible for delivering research and educational meetings and policy forums across the globe. She was the Scientific Chairman of the World Congress of Nephrology in Hong Kong in 2013.


Board members

photo of Ms Katherine Boiciuc

Ms Katherine Boiciuc

Ms Katherine Boiciuc is a Director at Maximus International and a global leader with extensive experience in the technology and telco industries. She has held senior and influential roles focused on the global impact and enablement of technology.

Ms Boiciuc joined Maximus after 19 years at Telstra where her team, across 20 countries, delivered services such as risk and compliance, strategic execution, customer experience strategy and Net Promoter Score measurement, and digital enablement including deployment of Tableau, Salesforce and Einstein.

Ms Boiciuc is an advocate and global keynote speaker on diversity and women in technology, and women in data. She is an accredited futurist and was one of 29 Australian women recognised for her contributions to science, technology, engineering and mathematics (STEM). She has a rich catalogue of blogs and articles on mentoring advice to women in digital, data, STEM and tech leadership roles.

With a focus on supporting leaders to adapt and grow by embracing disruption, experimenting with new technology and embedding new ways of leading in daily practice, she enjoys enabling leaders and their teams to be future ready and thrive amongst increasingly complex change.

Ms Boiciuc has worked with organisations including AGL Australia, CyberCX, Transport for NSW, and the Australian Securities and Investments Commission.


photo of Mr Ian Gillespie

Mr Ian Gillespie

Mr Ian Gillespie has an extensive background in the public and private sectors, holding senior executive positions covering finance, administration, strategy and general management.

His previous appointments including senior Finance Director positions at the Department of Education and Communities; General Manager, Finance at the NSW TAFE Commission; Director, Finance and Administration and also Director, Strategic Planning at the Ministry of Education and Youth Affairs; and Chief Accountant at the NSW Department of Motor Transport.

Mr Gillespie has undertaken independent consultancies covering service outcomes, risk management, policy setting, financial management and corporate restructuring. He has been appointed to various government committees where service enhancement, strategic risk management, probity issues and compliance with government regulatory requirements were paramount. He is currently appointed to several government committees addressing audit and risk management.

Mr Gillespie is a Fellow with CPA Australia; Fellow of the Australian Institute of Management; and is a member of the Australian Institute of Company Directors.


photo of Dr Karen Luxford

Dr Karen Luxford

Dr Karen Luxford is the Group Chief Executive Officer (CEO) of the Australian Council on Healthcare Standards (ACHS) and ACHS International. She has extensive experience in governance, strategic planning, safety and quality, healthcare standards, stakeholder engagement and organisational change.

Dr Luxford is a senior executive in health with more than 25 years’ experience in a range of leadership roles in the public, not-for-profit and private sectors including CEO of the Royal Australasian College of Dental Surgeons, A/CEO and Executive Director of the Clinical Excellence Commission, and General Manager of the National Breast and Ovarian Cancer Centre.

Dr Luxford is a Board member and President-elect of the Australian Skills Quality Authority, Board member of Camp Quality, former Board Chair of Endometriosis Australia, Council member of Standards Australia, member of the International Society for Quality in Health Care Accreditation Council, Graduate of the Australian Institute of Company Directors, Certified Health Executive and Fellow of the Australasian College of Health Service Management and the Australian Institute of Managers and Leaders.

Dr Luxford is an alumni Harkness Fellow in Healthcare Policy and Practice at Harvard Medical School in Boston and is passionate about healthcare.


Photo of Professor Sallie Pearson

Professor Sallie Pearson

Professor Sallie Pearson heads the medicines policy research unit at the Centre for Big Data Research in Health, UNSW Sydney. She is also the Director of the National Health and Medical Research Council Centre of Research Excellence in Medicines Intelligence.

Professor Pearson is a leading authority on population-based research using routinely collected data, particularly regarding the quality use of prescribed medicines. She has led national and international studies leveraging ‘big health data’ to generate real-world evidence on the use, benefits and safety of prescribed medicines.

Professor Pearson has published more than 250 peer reviewed manuscripts in leading journals including Lancet Oncology, Journal of Clinical Oncology, Annals of Oncology, JAMA Internal Medicine, NEJM and Pharmacoepidemiology and Drug Safety.

Professor Pearson is a long-standing advocate for the safe and productive use of data to benefit the Australian community. She has written widely on maximising the value of data for decision making in health and as an active member of peak medicines policy and health data linkage committees and advisory groups. These include the drug utilisation subcommittee of the Pharmaceutical Benefits Advisory Committee (2011–current), the National COVID-19 Clinical Taskforce (Co-Chair, 2020–current) and others.

During her tenure as Chair/Deputy Chair of the NSW Population Health Service Research Ethics Committee (2006–2017), Professor Pearson shaped policy around the ethics and governance of health data linkage for research.


photo of Diane Watson

Dr Diane WatsonChief Executive

Dr Diane Watson is the Chief Executive of the Bureau of Health Information (BHI) in NSW. She has led the establishment of three reporting agencies in Australia that use big data to drive decisions on healthcare provision nationally and locally.

Dr Watson was the inaugural Chief Executive of BHI from 2009 to 2012 before returning to the role in 2018 to further drive its work reporting on the performance of the NSW healthcare system.

In between these tenures at BHI, Dr Watson was the inaugural Chief Executive of the National Health Performance Authority, established by the Australian Government to monitor, and report on, the performance of 1000+ public and private hospitals and 300+ health regions. She was also the inaugural Chief Executive Officer of the Victorian Agency for Health Information, established to monitor and report on public and private services that stimulate quality and safety improvements, increase transparency and accountability, and inform the community.

Dr Watson has held senior management positions for more than 30 years measuring, monitoring and reporting on the performance of healthcare systems to drive improvements in health, patient care and productivity. During this time, she has set the future direction of high profile, board-governed agencies and inspired a strong sense of purpose among a highly talented and specialised workforce.


Page updated: 27 Sep 2022